
Bioorganic and Medicinal Chemistry Letters p. 3577 - 3582 (1998)
Update date:2022-08-04
Topics:
Chambers
Antognoli
Cheng
Kuperman
Liston
Marfat
Owens
Pillar
Shirley
Watson
A new series of cysLT1 receptor antagonists represented by CP-288,886 (7) and CP-265,298 (8) were developed which are equipotent to clinical cysLT1 receptor antagonists Zafirlukast (1) and Pranlukast (2).
View MoreSuZhou Ascepion Pharmaceuticals, Inc.(expird)
Contact:0512-86881668
Address:Building C,68Xingqing Road,Suzhou,China.
Contact:86-571-86737118-8689
Address:No.69, 12 Street, HEDA, Hangzhou, Zhejiang, China
Shenzhen HwaGen Pharmaceutical Co., Ltd
website:http://www.rafflespt.com
Contact:+86-752-5538396
Address:Guangdong Huizhou China
Contact:86-15588110016
Address:LINYI CITY,SHANDONG PROVINCE,CHINA
Fujian Wanke Pharmaceutical Co., LTD.
Contact:+86-598-5026002
Address:Economic development zone,jiangle county
Doi:10.1021/ja4098803
(2013)Doi:10.1021/ja00217a003
(1988)Doi:10.1016/j.tetlet.2013.10.156
(2014)Doi:10.1021/ja056505c
(2006)Doi:10.1016/j.tet.2020.131635
(2020)Doi:10.1002/ejoc.201801318
(2018)